Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Emergence of Novel Norovirus GII.4 Variant

Preeti Chhabra et al. Emerg Infect Dis. 2024 Jan.

Abstract

We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017-2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.

Keywords: South Africa; United Kingdom; United States; acute gastroenteritis; enteric infections; norovirus; viruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phylogenetic trees of the emerging novel norovirus GII.4 strains on 3 continents. A) Common genotyping region C; 250 nt from the 5′ end of ORF2; B) complete VP1 aa sequences. Phylogenetic trees show novel GII.4 San Francisco strains and GII.4 variants, including recently identified clusters like GII.4 Hong Kong. Evolutionary analyses were conducted in MEGA X (https://www.megasoftware.net) using the maximum-likelihood method based on the Tamura-Nei model for the C region and Jones-Taylor-Thornton matrix-based model for VP1. We used a discrete gamma distribution to model evolutionary rate differences among sites; 5 categories γ parameter = 0.2174. Bootstrap (100) values are indicated at the nodes. Trees were drawn to scale. Scale bar represents nucleotide substitutions per site. ORF, open reading frame; VP1, viral protein 1.
Figure 2
Figure 2
Structural changes of emergent novel norovirus GII.4 strains from 3 continents. A) Sydney GII.4 strain (GenBank accession no. JX459908); B) GII.4 San Francisco strain. The 3-dimensional structure models were predicted by using ChimeraX version 1.4 (11) and the alphafold prediction tool (12). Models show structural changes near and within the epitope A antigenic region on GII.4 San Francisco P-domain (panel B) are overlayed on a GII.4 Sydney 2012 backbone (Protein Data Bank, https://www.rcsb.org/structure/4OP7). Negatively (red) and positively (green) charged amino acids of GII.4 Sydney (panel A) were replaced with neutral amino acids (blue) in the GII.4 San Francisco strain and a hydrophobic (yellow) amino acid, alanine, was inserted between T293 and T294.

References

    1. Chhabra P, de Graaf M, Parra GI, Chan MC, Green K, Martella V, et al. Updated classification of norovirus genogroups and genotypes. J Gen Virol. 2019;100:1393–406. 10.1099/jgv.0.001318 - DOI - PMC - PubMed
    1. Farahmand M, Moghoofei M, Dorost A, Shoja Z, Ghorbani S, Kiani SJ, et al. Global prevalence and genotype distribution of norovirus infection in children with gastroenteritis: A meta-analysis on 6 years of research from 2015 to 2020. Rev Med Virol. 2022;32:e2237. 10.1002/rmv.2237 - DOI - PubMed
    1. Parra GI, Tohma K, Ford-Siltz LA, Eguino P, Kendra JA, Pilewski KA, et al. Minimal antigenic evolution after a decade of norovirus GII.4 Sydney_2012 circulation in humans. J Virol. 2023;97:e0171622. 10.1128/jvi.01716-22 - DOI - PMC - PubMed
    1. Lindesmith LC, Boshier FAT, Brewer-Jensen PD, Roy S, Costantini V, Mallory ML, et al. Immune imprinting drives human norovirus potential for global spread. MBio. 2022;13:e0186122. 10.1128/mbio.01861-22 - DOI - PMC - PubMed
    1. Cannon JL, Barclay L, Collins NR, Wikswo ME, Castro CJ, Magaña LC, et al. Genetic and epidemiologic trends of norovirus outbreaks in the United States from 2013 to 2016 demonstrated emergence of novel GII.4 recombinant viruses. J Clin Microbiol. 2017;55:2208–21. 10.1128/JCM.00455-17 - DOI - PMC - PubMed